findmyKOL

Roy Herbst, MD, PhD

Enriched profile

Deputy Director, Yale Cancer Center; Chief of Medical Oncology and Hematology, Yale Cancer Center and Smilow Cancer Hospital; Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology, Yale School of Medicine (through mid-July 2026; named Director of Dartmouth Cancer Center, effective July 13, 2026) · Yale School of Medicine

ORCID↗NPINone on file
✓ Full profile
RegionNot on fileSpecialtyMedical OncologyFocusLung Cancer Treatments and Mutations+4
Active KOLLatest publication2026Online presenceverified 2026PaymentsNot attributedNIH funding2001–2010Why? →

Roy Herbst is Deputy Director, Yale Cancer Center; Chief of Medical Oncology and Hematology, Yale Cancer Center and Smilow Cancer Hospital; Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology, Yale School of Medicine (through mid-July 2026; named Director of Dartmouth Cancer Center, effective July 13, 2026) at Yale School of Medicine. OpenAlex indexes 1,336 publications with 94,089 citations (h-index 135); ClinicalTrials.gov lists 8 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Roy S. Herbst is Deputy Director, Yale Cancer Center at Yale School of Medicine / Yale Cancer Center (transitioning to Dartmouth Cancer Center as Director effective July 13, 2026). The public record shows 1,336 publications with 94,089 citations (h-index 135), centered on Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Lung Cancer Research Studies. It also documents an investigator role on 8 registered clinical trials, 2 NIH-funded awards (2001–2010).

  • Most recent indexed publication: 2026 · Cancer discovery
  • Top research focus: Lung Cancer Treatments and Mutations
  • 8 registered trials on ClinicalTrials.gov

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Lung Cancer (NSCLC/SCLC)4 trialsHead & Neck Cancer2 trialsAdenocarcinoma of Lung1 trial

Research focus

OpenAlex concept fingerprint
Lung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersLung Cancer Research StudiesLung Cancer Diagnosis and TreatmentCancer Genomics and Diagnostics

Drugs & molecules

across trials, industry payments and publications
CarboplatinClinical trials2Industry payments—Publications4PaclitaxelClinical trials2Industry payments—Publications4Avastingeneric · BevacizumabClinical trials2Industry payments—Publications1Tarcevageneric · ErlotinibClinical trials1Industry payments—Publications2CisplatinClinical trials1Industry payments—Publications1GemcitabineClinical trials1Industry payments—Publications1CetuximabClinical trials2Industry payments—Publications—OrantinibClinical trials1Industry payments—Publications—Peginterferon alfa-2bClinical trials1Industry payments—Publications—Recombinant human endostatinClinical trials1Industry payments—Publications—ThalidomideClinical trials1Industry payments—Publications—TrastuzumabClinical trials1Industry payments—Publications—

Works with

trial sponsors and companies reporting payments
M.D. Anderson Cancer CenterClinical trials3Industry payments—National Cancer Institute (NCI)Clinical trials3Industry payments—SWOG Cancer Research NetworkClinical trials2Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
1,336publications

Distinct works indexed by OpenAlex, matched via ORCID; 29 in PubMed.

94,089citations

Total citations across indexed works.

135h-index

Hirsch index (OpenAlex). i10-index 487.

Clinical & industry

trials, payments and federal funding
8clinical trials

Investigator role on registered studies.

View trials ↓
—payment companies

Not shown. No U.S. clinical registration on file.

2NIH grants · 2001–2010

Federally funded research awards.

View funding ↓

Public positions

sourced statements on record

This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →

Contact

An office address from a public listing. This research profile has no federal registry record to draw from.

Office address

Smilow Cancer Hospital, 35 Park St, New Haven, CT 06519

From the cited public source.Collected 14 Oct 2026.View source ↗

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:

All 8 trial records: search, sort and filter.Explore →

Industry payments

Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →

NIH funding

Updated 14 Oct 2026

2 NIH research awards on record, funded 2001–2010 per NIH RePORTER. The latest:

All 64 award records: search, sort and filter.Explore →

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 29 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
    6,540 citations2015
    doi.org ↗
  2. 02
    Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
    5,268 citations2014
    doi.org ↗
  3. 03
    The biology and management of non-small cell lung cancer
    4,963 citations2018
    doi.org ↗
  4. 04
    Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
    2,538 citations2003
    doi.org ↗
  5. 05
    Lung Cancer
    2,392 citations2008
    doi.org ↗
All 1,336 cited works: search, sort and filter.Explore →

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Ignacio I. Wistuba199Kurt A. Schalper186John V. Heymach157Scott Gettinger154Mary W. Redman138Karen Kelly126David L. Rimm123Waun Ki Hong118David R. Gandara107John D. Minna99Sarah B. Goldberg94Vassiliki A. Papadimitrakopoulou92Luc Girard87Hai T. Tran87Edward S. Kim86Scott M. Lippman80Fred R. Hirsch77George R. Blumenschein76Lixia Diao76Miguel F. Sanmamed75Katerina Politi72Ximing Tang69Lieping Chen66Michael Peyton64Philip C. Mack62Uma Giri61Pierre Saintigny60Frank V. Fossella58Carmen Behrens57Ila Datar56Vamsidhar Velcheti56Margarita Majem53Lauren A. Byers53Monique B. Nilsson52Anne S. Tsao51Kevin R. Coombes51Edwin R. Parra50Jhanelle E. Gray49Anne C. Chiang49Jing Wang49

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/roy-herbst-16b260106

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • Google Scholar

    scholar.google.com/citations

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholar.google.com ↗
  • ResearchGate

    researchgate.net/scientific-contributions/Roy-S-Herbst-38649626

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • X / Twitter

    x.com/DrRoyHerbstYale

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/SmilowCancerHospital/posts/dr-roy-herbst-deputy-director-of-yale-cancer-center-and-chief-of-medical-oncolog/6486531174725448

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
  • Instagram

    instagram.com/p/C4WkX7AM_Tw

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗
  • ResearchGate

    researchgate.net/scientific-contributions/Roy-Herbst-2179118794

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
  • Other

    yalemedicine.org/podcasts/2025-yca-0316-podcast-herbst

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →yalemedicine.org ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • LinkedIn

    LinkedIn profile lists him as "Incoming Cancer Center Director Dartmouth" (title updated ahead of July 13, 2026 start)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Fellowship

    Medical Oncology, Dana-Farber Cancer Institute

    1997
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • M.S.

    Clinical Translational Research, Harvard University

    1997
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Residency

    Internal Medicine, Brigham and Women's Hospital

    1994
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • M.D.

    Cornell University Medical College

    1991
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Ph.D.

    Molecular Biology/Cell Biology, The Rockefeller University

    1990
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • B.S./M.S.

    Molecular Biophysics & Biochemistry, Yale University

    1984
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Board Certified

    Medical Oncology (American Board of Internal Medicine)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗

Editorial & leadership roles

journal and society appointments
  • Board Director

    Friends of Cancer Research

    2024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Board Member

    American Association for Cancer Research (AACR), 2020-2023 term

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Board Member

    International Association for the Study of Lung Cancer (IASLC), since 2019

    2019
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Committee Member

    National Cancer Institute Thoracic Malignancy Steering Committee

    2012
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Fellow

    American Society of Clinical Oncology (ASCO)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗

Awards & honors

honors on the public record
  • Elected

    Connecticut Academy of Science and Engineering

    2025
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Ezra Greenspan Award

    Chemotherapy Foundation

    2024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Giants of Cancer Care Award for Lung Cancer
    2022
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • AACR Distinguished Public Service Award
    2020
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Paul A. Bunn

    Jr. Scientific Award, IASLC

    2016
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Elected member

    Association of American Physicians

    2015
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.yale.edu ↗
  • Fellow

    American College of Physicians

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →winconsortium.org ↗

Secondary affiliations

appointments beyond the home institution
  • Assistant Dean

    Office of the Dean, Yale School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Program Director

    Master of Health Science - Clinical Investigation Program (MHS-CI), Yale School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Secondary appointment

    Department of Pharmacology, Yale School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Program faculty

    Immunobiology, Yale School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Founding Principal Investigator

    NCI-funded Yale SPORE in Lung Cancer

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →yalecancercenter.org ↗

Media & interviews

press, podcasts and appearances
  • Guest

    "50 Years of Cancer Progress: Medical Oncology," Yale Cancer Answers podcast

    2025
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →yalemedicine.org ↗
  • Interview

    "Making a Mark in Lung Cancer: An Interview With Roy S. Herbst, MD, PhD," OncLive/Oncology Live

    2011
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
  • Listed expert commentator

    Yale Office of Public Affairs & Communications media experts directory

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →communications.yale.edu ↗
  • X/Twitter account @DrRoyHerbstYale
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.